|
NIPSNAP3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.02590000000825E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.238200E-04 |
| Normal-vs-Stage2 |
2.042500E-04 |
| Normal-vs-Stage3 |
1.037990E-03 |
| Normal-vs-Stage4 |
3.820600E-04 |
| Stage1-vs-Stage2 |
4.062200E-01 |
| Stage1-vs-Stage3 |
6.474400E-01 |
| Stage1-vs-Stage4 |
2.707800E-01 |
| Stage2-vs-Stage3 |
8.474000E-01 |
| Stage2-vs-Stage4 |
4.302400E-01 |
| Stage3-vs-Stage4 |
4.506600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78663000000023E-05 |
| Normal-vs-AfricanAmerican |
1.381700E-02 |
| Normal-vs-Asian |
4.318600E-03 |
| Caucasian-vs-AfricanAmerican |
1.000790E-01 |
| Caucasian-vs-Asian |
4.012000E-01 |
| AfricanAmerican-vs-Asian |
2.209000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.455400000003E-05 |
| Normal-vs-Female |
2.849500E-04 |
| Male-vs-Female |
8.924800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.23240000005076E-06 |
| Normal-vs-Extreme_Weight |
2.0799999999932E-05 |
| Normal-vs-Obese |
6.845700E-04 |
| Normal-vs-Extreme_Obese |
5.383600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.174600E-01 |
| Normal_Weight-vs-Obese |
1.687550E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.920600E-01 |
| Extreme_Weight-vs-Obese |
7.016800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.588800E-01 |
| Obese-vs-Extreme_Obese |
5.244600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.595300E-04 |
| Normal-vs-Age(41-60Yrs) |
8.577200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.581140E-04 |
| Normal-vs-Age(81-100Yrs) |
1.223730E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.882600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.878200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.993000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.628400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.042400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.363000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.584510E-04 |
| Normal-VS-Type2 PRCC |
2.984700E-04 |
| Normal-VS-KIRP CIMP |
5.220600E-03 |
| Normal-VS-Unclassified PRCC |
1.443820E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.842400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.517000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.063000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.780200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.099600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.038600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.811300E-04 |
| Normal-vs-N1 |
1.600860E-04 |
| Normal-vs-N2 |
2.153200E-04 |
| N0-vs-N1 |
9.099400E-01 |
| N0-vs-N2 |
1.151750E-01 |
| N1-vs-N2 |
5.652000E-02 |
|
|
